NDC00089-0221-10 — ORPHENADRINE CITRATE EXTENDED-RE

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00089-0221-10: ORPHENADRINE CITRATE EXTENDED-RE.

ORPHENADRINE CITRATE EXTENDED-RE. Key specifications include primary_container_type: BOTTLE, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS 100 MG 100 TABS BT. This part is cataloged in the U.S.

Government catalog under NSN 6505-00-138-8462, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00089-0221-10

NSN: 6505-00-138-8462
FSC: 6505 — Drugs and Biologicals
CAGE: 04515 — 3M COMPANY HEALTH CARE/MFG (USA)

SPECIFICATIONS

primary_container_type	BOTTLE
primary_container_content_quantity	100.000 TABLETS
active_medicament_medicinal_strength	100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS 100 MG 100 TABS BT
NSN	6505-00-138-8462

COMPONENT DIAGRAM

KEY FEATURES

•

PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS

•

PRIMARY CONTAINER TYPE: BOTTLE

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

PRIMARY CONTAINER CONTENT QUANTITY	100.000 TABLETS
PRIMARY CONTAINER TYPE	BOTTLE
PART NAME ASSIGNED BY CONTROLLING AGENCY	ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS 100 MG 100 TABS BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH	100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT

SUBSTITUTES & CROSS-REFERENCES 2

NORFLEX TABLETSReference document

Same NSN cross-reference

Reference document — Secondary reference

NORFLEXReference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusCancelled· U.S. Government catalog

HAZMAT per U.S. Government catalogNo demilitarization required

Ready to buy NDC00089-0221-10?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00089-0221-10?

NDC00089-0221-10 is a ORPHENADRINE CITRATE EXTENDED-RE.

What parts can replace NDC00089-0221-10?

There are 2 known substitutes for NDC00089-0221-10: NORFLEX TABLETS, NORFLEX. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00089-0221-10?

NDC00089-0221-10 is cataloged in the U.S. Government catalog under NSN 6505-00-138-8462. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00089-0221-10 — ORPHENADRINE CITRATE EXTENDED-RE

Request a Quote — NDC00089-0221-10